GEOGRAPHIC ATROPHY
Clinical trials for GEOGRAPHIC ATROPHY explained in plain language.
Never miss a new study
Get alerted when new GEOGRAPHIC ATROPHY trials appear
Sign up with your email to follow new studies for GEOGRAPHIC ATROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood-Derived injection shows promise for dry AMD
Disease control CompletedThis study tested whether injecting a concentrated form of a patient's own blood, called platelet-rich plasma (PRP), into the eye could slow the progression of advanced dry age-related macular degeneration (AMD). Fourteen people with dry AMD received three PRP injections in one e…
Matched conditions: GEOGRAPHIC ATROPHY
Phase: NA • Sponsor: Marmara University Pendik Training and Research Hospital • Aim: Disease control
Last updated May 17, 2026 04:36 UTC
-
Eye drug safety check for advanced macular degeneration
Disease control CompletedThis study looks at the long-term safety of an eye injection called avacincaptad pegol for people with geographic atrophy, a form of advanced age-related macular degeneration that causes vision loss. It includes 278 adults aged 50 and older who already completed a previous study …
Matched conditions: GEOGRAPHIC ATROPHY
Phase: PHASE3 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated May 17, 2026 04:30 UTC
-
New hope for dry AMD: drug aims to slow geographic atrophy
Disease control CompletedThis study tested an experimental drug called ALK-001 in people with geographic atrophy, an advanced form of dry age-related macular degeneration that causes blind spots. About 200 participants received the drug and 100 received a placebo. The goal was to see if ALK-001 could slo…
Matched conditions: GEOGRAPHIC ATROPHY
Phase: PHASE2, PHASE3 • Sponsor: Alkeus Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 17, 2026 04:14 UTC
-
New drug shows promise in slowing blindness from dry AMD
Disease control CompletedThis study tested an eye injection called Zimura (avacincaptad pegol) in 448 people with geographic atrophy, a form of advanced dry age-related macular degeneration that causes permanent vision loss. The goal was to see if the drug could slow the growth of damaged areas in the re…
Matched conditions: GEOGRAPHIC ATROPHY
Phase: PHASE3 • Sponsor: IVERIC bio, Inc. • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Gene therapy shows promise in slowing dry AMD-related blindness
Disease control CompletedThis study tested a gene therapy called JNJ-81201887 in 305 people with geographic atrophy, a severe form of dry age-related macular degeneration that causes blind spots. The treatment was injected into the eye and compared to a sham procedure. The goal was to see if it could slo…
Matched conditions: GEOGRAPHIC ATROPHY
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC
-
Scientists track vision loss in dry macular degeneration
Knowledge-focused CompletedThis study looked at how vision gets worse over time in people with geographic atrophy, an advanced form of dry age-related macular degeneration. Researchers used past medical records and eye scans from 60 patients to see which changes in the retina are linked to faster vision lo…
Matched conditions: GEOGRAPHIC ATROPHY
Sponsor: IRCCS Ospedale San Raffaele • Aim: Knowledge-focused
Last updated May 13, 2026 15:59 UTC